查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776209

球囊導管的全球市場:洞察，競爭情形，市場預測:2032年

Balloon Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2024年，球囊導管市場規模為49.7201億美元。預計到2032年，該市場規模將達到89.2876億美元，2025年至2032年的複合年增長率為7.63%。心血管疾病、腦動脈瘤和骨盆腔癌的發生率不斷上升，大大推動了球囊導管市場的發展。隨著心血管疾病的日益普遍，對球囊導管的需求也日益增長。球囊導管對於治療腦動脈瘤和增強骨盆腔癌的藥物傳遞也至關重要。同時，主要市場參與者的產品開發正在推動藥物洗脫球囊和生物可吸收球囊等創新技術的出現。這些因素共同推動了球囊導管市場的發展，因為醫療保健提供者正在尋求有效的解決方案來滿足不同患者群體的臨床需求。預計這些綜合因素將在2025年至2032年的預測期內推動球囊導管市場的發展。

球囊導管市場動態：

根據英國心臟基金會（British Heart Foundation）的最新數據（2025年），全球約有6.4億人患有心臟和循環系統疾病，約每12人中就有1人患有此類疾病。英國心臟基金會（British Heart Foundation）的進一步數據（2024年）表明，冠狀動脈（缺血性）心臟病是全球最常見的心血管疾病，影響約2億人，其中包括約1.1億男性和8,000萬名女性。此外，全球約有5600萬女性和4500萬男性中風後存活下來。此外，至少有1,300萬人患有先天性心臟病，還有數百萬人可能尚未確診。

全球心血管疾病（包括冠狀動脈疾病、週邊動脈疾病和中風）的盛行率不斷上升，推動了對有效微創幹預措施的需求。經皮腔內冠狀動脈成形術 (PTCA) 就是這樣一種幹預措施，它使用球囊導管打開狹窄或阻塞的動脈並恢復血流，從而降低心臟病發作和中風的風險。隨著心血管疾病負擔的持續加重，預計 PTCA 和 PCI 手術的數量將會增加，這將直接推動對 PTCA 球囊導管的需求並支持市場擴張。

除了心血管應用外，球囊導管在管理癌症相關併發症方面也發揮著重要作用。根據 GLOBOCAN (2022) 的數據，預計全球腎癌新病例約為 43.5 萬例，到 2045 年將增至 69.3 萬例。同樣，膀胱癌新發病例估計在 2022 年為 61.4 萬例，預計到 2045 年將達到 112 萬例。骨盆腔癌會阻塞輸尿管，阻礙尿液從腎臟流向膀胱，導致尿液滯留和腎臟損傷。在這種情況下，通常會進行腎造口術，通常會使用腎造口球囊導管建立尿液引流通道。隨著骨盆腔癌發病率的上升，預計對球囊導管的需求將增加，進一步推動全球球囊導管市場的成長。 此外，持續的產品創新和監管審批正在推動市場發展。例如，2024年7月，泰利福公司（Teleflex Incorporated）的Ringer™灌注球囊導管（PBC）獲得了FDA 510(k)批准，這是目前唯一一款市售的PTCA灌注球囊導管。此球囊導管採用快速交換設計，其螺旋球囊在充氣後會變成空心，即使在長時間球囊擴張期間也能維持冠狀動脈血流。它用於擴張冠狀動脈狹窄部位以及需要遠端灌注的旁路移植術。

然而，市場也面臨挑戰。與球囊導管手術相關的風險，例如動脈剝離、血管穿孔和栓塞，可能導致嚴重的併發症。此外，由於品質和安全問題導致的產品召回事件增多，可能會阻礙未來的市場成長。

由於心血管疾病和癌症發病率的上升以及技術創新的進步，全球球囊導管市場預計將實現顯著增長。然而，持續關注器械安全性和品質對於維持長期市場擴張至關重要。

球囊導管市場區隔分析：

預計到2024年，非順應性球囊導管類別將佔據以球囊類型劃分的球囊導管市場的最大佔有率。非順應性球囊能夠保持其形狀和大小，從而能夠更可預測和控制地擴張狹窄或阻塞的血管。這項特性使其在高壓應用中特別有利，例如冠狀動脈疾病的治療，在這種應用中，精確的球囊尺寸對於獲得最佳療效且不損傷周圍組織至關重要。非順應性球囊的卓越性能可降低血管成形術等手術中發生球囊破裂和血管創傷等併發症的風險，從而獲得更好的治療效果。隨著醫療保健提供者越來越認識到這些專用球囊導管的優勢，對非順應性球囊導管的需求也不斷增長。

此外，材料技術和設計的進步使非順應性球囊更加有效且用途廣泛，從而推動了其在各個醫療領域的應用。這種向非順應性球囊導管的轉變不僅提高了手術成功率，也推動了整個球囊導管市場的發展。例如，2023年9月，Kossel Medtech的Sabelly®非順應性週邊球囊擴張導管獲得了中國國家藥品監督管理局的市場批准。此導管專為週邊血管成形術設計，是首個經批准的國產大直徑球囊導管，有助於減少對進口產品的依賴。

因此，預計該細分市場的收入將在預測期內大幅成長，從而推動全球球囊導管市場的整體成長。

預計北美將主導整個球囊導管市場：

在所有地區中，預計到2024年，北美將佔據全球球囊導管市場的最大佔有率。球囊導管市場的主要推動因素包括：生活方式相關疾病的盛行率不斷上升，這些疾病導致腦動脈瘤、膀胱癌、良性前列腺增生和尿瀦留等泌尿系統疾病以及各種心血管疾病的發生；以及該地區對產品開發的日益重視。這些因素共同作用，預計將推動該地區整個球囊導管市場的發展。

根據美國心臟協會（2023年）發布的數據，美國每年進行超過50萬例經皮冠狀動脈介入治療，其中經皮腔內冠狀動脈成形術佔很大比例。因此，心血管疾病盛行率的上升以及隨之而來的PCI手術的增加預計將進一步推動對刻劃和切割球囊導管的需求。據估計，這將有助於北美球囊導管市場的成長。

腦動脈瘤盛行率的上升也促進了北美球囊導管市場的成長。根據腦動脈瘤基金會（2023年）的統計數據，美國每年約有3萬人患有腦動脈瘤破裂。美國癌症協會的單獨數據估計，2023年美國將有約24,350例腦部或脊髓惡性腫瘤。此外，據估計，2023年美國將有約18,600人死於腦部或脊髓腫瘤。這些適應症通常使用閉塞球囊導管治療，這種導管專門設計用於神經血管系統的給藥。因此，腦動脈瘤盛行率的上升也有望推動球囊導管需求，並支持北美球囊導管市場的成長。

此外，整個地區的產品開發活動也有望推動該地區整體球囊導管市場的發展。例如，2023年8月，上海微創醫療（MicroPort® Coronary）的Firefighter™ NC Pro PTCA球囊導管獲得美國食品藥物管理局（FDA）批准。這款新一代高壓球囊專為擴張狹窄冠狀動脈和支架置入術後手術而設計。其三層複合球囊和高達22個大氣壓的爆破壓力可有效治療鈣化等頑固性病變。

因此，預計上述因素將在預測期內推動該地區北美球囊導管市場的發展。

球囊導管市場的主要參與者

球囊導管市場的主要公司包括美敦力、波士頓科學公司、雅培、庫克、B. Braun Melsungen AG、康德樂、泰爾茂公司、史賽克、泰利福公司、微創科學公司、百多力、尼普洛醫療公司、BD、康樂保、Summit Medical（Innovia Medical）、百多力、尼普洛醫療公司、BD、康樂保、Summit Medical（Innovia Medical）、威普威特醫療有限公司（北京科技有限公司）。

球囊導管市場的最新發展：

  • 2024 年 3 月，波士頓科學公司宣布 FDA 批准 AGENT™ 藥物塗層球囊 (DCB) 導管，用於治療冠狀動脈疾病患者的冠狀動脈支架內再狹窄 (ISR)。疾病。
  • 2022年5月，美敦力宣布美國食品藥物管理局 (FDA) 批准了IN.PACT 018紫杉醇塗層經皮腔內血管成形術 (PTA) 球囊導管，這是一種藥物塗層球囊 (DCB)，適用於介入治療股淺動脈和膕動脈的外周動脈疾病 (PAD)。

球囊導管市場研究報告主要內容

  • 目前球囊導管市場規模分析（2024 年）及八年市場預測（2025-2032 年）
  • 過去三年主要產品/技術發展、併購、合作及合資企業
  • 主導球囊導管市場的主要公司
  • 球囊導管市場中的競爭對手的商業機會
  • 2024 年的主要細分市場及其 2030 年的表現
  • 目前球囊導管市場的主要地區和國家
  • 企業應關注哪些地區和國家以把握未來球囊導管市場的成長機會

球囊導管市場相關常被詢問的問題

1.球囊導管

  • 球囊導管是一種尖端連接有球囊的柔性導管。此類導管用於各種微創診斷和治療操作，例如疏通阻塞、擴張血管和置入支架。

2. 球囊導管市場

  • 預計2024年球囊導管市場價值將達到49.7201億美元，預計2025年至2032年期間的複合年增長率為7.63%，到2032年將達到89.2876億美元。

3. 球囊導管市場的推動因素

  • 心血管疾病、腦動脈瘤和骨盆腔癌盛行率的上升顯著推動了球囊導管市場的發展。隨著心血管疾病的日益普遍，對球囊導管的需求也不斷增加。球囊導管對於治療腦動脈瘤和增強骨盆腔癌的藥物傳遞也至關重要。同時，主要市場參與者在產品開發的進步，催生了藥物洗脫球囊和生物可吸收球囊等創新技術。這些因素共同推動了球囊導管市場的發展，因為醫療保健提供者正在尋求有效的解決方案來滿足日益多樣化的患者群體的臨床需求。預計在2025年至2032年的預測期內，這些因素將推動球囊導管市場的發展。

4.球囊導管市場的主要參與者

  • 球囊導管市場的主要公司包括美敦力、波士頓科學公司、雅培、庫克、B. Braun Melsungen AG、康德樂、泰爾茂公司、史賽克、泰利福公司、微創科學公司、百多力、尼普洛醫療公司、BD、康樂保、Summit Medical（Innovia Medical Medical）、百多力、尼普洛醫療公司、BD、康樂保、Summit Medical（Innovia Medical）、威普威特醫療有限公司（北京科技有限公司）。

5.球囊導管市佔率最大的地區

  • 在所有地區中，預計北美將在2024年佔據全球球囊導管市場的最大佔有率。球囊導管市場的主要推動因素包括：生活方式相關疾病的盛行率不斷上升，導致腦動脈瘤、膀胱癌、良性前列腺增生、尿瀦留等泌尿系統疾病以及各種心血管疾病的發生；以及該地區對產品開發活動的日益重視。這些因素預計將推動該地區整體球囊導管市場的發展。

目錄

第1章 球囊導管市場報告的簡介

第2章 球囊導管市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 球囊導管市場主要原因分析

  • 球囊導管推動市場要素
    • 心血管疾病盛行率上升
    • 腦動脈瘤發生率上升
    • 骨盆腔癌發生率上升
    • 全球主要市場參與者的產品開發活動
  • 球囊導管市場的限制與挑戰
    • 球囊導管相關的手術風險
    • 產品召回不斷增加
  • 球囊導管市場機遇
    • 球囊導管安全展望及設計缺陷的持續改進

第6章 球囊導管市場:波特的五力分析

第7章 球囊導管市場評估

  • 各產品類型
    • PTA球囊導管
    • PTCA球囊導管
    • 閉塞球囊導管
    • 導尿管
    • 腎瘺球囊導管
    • 藥物釋放型導管
    • 其他
  • 導管類型
    • 固定線
    • OTW
    • 快速交換導管
  • 氣球類型
    • 不兼容
    • 半兼容
    • 順應性導管
  • 各終端用戶
    • 醫院
    • 專門診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 球囊導管市場企業與產品簡介

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Cook
  • B. Braun Melsungen AG
  • Cardinal Health
  • Terumo Corporation
  • Stryker
  • Teleflex Incorporated
  • Microport Scientific Corporation
  • BIOTRONIK
  • Nipro Medical Corporation
  • BD
  • Coloplast
  • Summit Medical (Innovia Medical)
  • Well Lead Medical Co., Ltd.
  • Smiths Medical
  • BACTIGUARD AB
  • JOTEC GmbH
  • Lepu Medical Technology(Beijing)Co.,Ltd.

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0314

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of cardiovascular diseases, growing prevalence of brain aneurysms, increasing prevalence of cancers in the pelvic region, and increase in product development activities by key market players across the globe.

The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032. The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

Balloon Catheters Market Dynamics:

According to recent data from the British Heart Foundation (2025), an estimated 640 million people worldwide approximately 1 in 12 individuals were living with heart and circulatory diseases. Further data from the British Heart Foundation (2024) highlighted that coronary (ischemic) heart disease was the most commonly diagnosed cardiovascular condition globally, affecting around 200 million people, including approximately 110 million men and 80 million women. Additionally, there were about 56 million female and 45 million male stroke survivors globally. Moreover, at least 13 million individuals lived with congenital heart disease, with millions potentially remaining undiagnosed.

The increasing global prevalence of cardiovascular disorders such as coronary artery disease, peripheral artery disease, and strokes is driving demand for effective, minimally invasive interventions. One such intervention is percutaneous transluminal coronary angioplasty (PTCA), which uses balloon catheters to open narrowed or blocked arteries and restore blood flow, thereby reducing the risk of heart attacks and strokes. As the burden of cardiovascular disease continues to rise, the number of PTCA and PCI procedures is expected to grow, directly fueling the demand for PTCA balloon catheters and supporting market expansion.

Beyond cardiovascular applications, balloon catheters also play a critical role in managing cancer-related complications. According to GLOBOCAN (2022), there were approximately 435,000 new cases of kidney cancer globally, a number projected to rise to 693,000 by 2045. Similarly, new bladder cancer cases were estimated at 614,000 in 2022, with projections reaching 1.12 million by 2045. Cancers in the pelvic region can obstruct the ureters, impairing urine flow from the kidneys to the bladder. This leads to a buildup of urine and potential kidney damage. In such cases, nephrostomy procedures are performed, often requiring nephrostomy balloon catheters to create a passage for urine drainage. As the incidence of pelvic cancers rises, the demand for these devices is expected to increase, contributing further to the growth of the global balloon catheter market.

Additionally, ongoing product innovation and regulatory approvals are boosting market momentum. For example, in July 2024, Teleflex Incorporated received FDA 510(k) clearance for its Ringer(TM) Perfusion Balloon Catheter (PBC) the only commercially available PTCA perfusion balloon catheter. Featuring a rapid-exchange design and helical balloon that forms a hollow cylinder when inflated, the device allows continuous coronary blood flow during prolonged inflations and is used for dilating coronary arteries or bypass graft stenoses where distal perfusion is necessary.

However, the market does face challenges. Risks associated with balloon catheter procedures such as arterial dissection, vessel perforation, or embolism can lead to serious complications. Moreover, increasing product recalls due to quality and safety issues may hinder future market growth.

In summary, while the global balloon catheters market is poised for significant growth due to rising cardiovascular and cancer cases and increasing innovation, ongoing vigilance regarding device safety and quality remains critical to sustaining long-term market expansion.

Balloon Catheters Market Segment Analysis:

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the balloon type segment of the balloon catheters market, the non-compliant balloon catheter category is expected to hold the largest share in the year 2024. Non-compliant balloons maintain their shape and size, providing a more predictable and controlled dilation of narrowed or obstructed vessels. This characteristic makes them particularly valuable in high-pressure applications, such as in the treatment of coronary artery disease, where precise balloon sizing is critical in achieving optimal results without damaging the surrounding tissue. The enhanced performance of non-compliant balloons leads to better outcomes in procedures like angioplasty, reducing the risk of complications such as balloon rupture or vessel trauma. As healthcare providers increasingly recognize the benefits of these specialized devices, the demand for non-compliant balloon catheters has grown.

Additionally, advancements in material technology and design are making non-compliant balloons more effective and versatile, further driving their adoption across various medical fields. This shift towards non-compliant balloon catheters not only enhances procedural success rates but also supports the expansion of the balloon catheter market as a whole. For instance, in September 2023, Kossel Medtech's Sabelly(R) non-compliant peripheral balloon dilatation catheter received market approval from China's NMPA. Designed for angioplasty in the peripheral vascular system, it became the first domestically produced large-diameter balloon catheter approved, helping to reduce reliance on imported products.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global balloon catheters market during the forecast period.

North America is expected to dominate the overall balloon catheter market:

Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

As per the data stated by the American Heart Association (2023), over 500,000 percutaneous coronary interventions were performed in the United States annually of which percutaneous transluminal coronary angioplasty holds a considerable share. Therefore, the rising prevalence of cardiovascular disorders as well as the subsequent increase in the number of PCI procedures being performed are further expected to boost the demand for scoring and cutting balloon catheters. This is estimated to contribute to the regional growth of the balloon catheters market in North America.

Another factor contributing to the regional growth of the North America balloon catheters market is the rising prevalence of brain aneurysms in the country. As per the statistics provided by the Brain Aneurysm Foundation (2023), approximately 30,000 people in the country suffer from a brain aneurysm rupture each year. In another set of data provided by the American Cancer Society, in 2023, it has been estimated that approximately 24,350 malignant tumors of the brain or spinal cord may occur in the US. It also estimated that in 2023, approximately 18,600 people were expected to succumb to brain and spinal cord tumors in the country. These indications are usually treated with occlusion balloon catheters specially devised for the administration in the neurovasculature. Therefore, the rising prevalence of brain aneurysms is also expected to drive the demand for such catheters, eventually boosting the growth of the market for balloon catheters in North America.

Additionally, product development activities across the region are further expected to boost the overall market of balloon catheters across the region. For instance, in August 2023, Shanghai MicroPort Medical (MicroPort(R) Coronary) received FDA approval for its Firefighter(TM) NC Pro PTCA Balloon Catheter. This next-generation high-pressure balloon was designed for dilating narrowed coronary arteries and post-stent procedures. With a three-layer composite balloon and a burst pressure of up to 22 atm, it effectively treated resistant lesions like calcifications.

Therefore, the factors mentioned above in the region are expected to boost the North America balloon catheters market during the forecast period.

Balloon Catheters Market Key Players:

Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

Recent Developmental Activities in the Balloon Catheters Market:

  • In March 2024, Boston Scientific Corporation announced the approval of the FDA for the AGENT(TM) Drug-Coated Balloon (DCB) catheter, which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.
  • In May 2022, Medtronic announced the approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.

Key takeaways from the balloon catheters market report study:

  • Market size analysis for current balloon catheters size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the balloon catheters market.
  • Various opportunities available for the other competitors in the balloon catheters market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current balloon catheter market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for balloon catheter market growth in the coming future?

Target audience who can benefit from this balloon catheter market report study:

  • Balloon catheter product providers
  • Research organizations and consulting companies
  • Balloon catheters-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in balloon catheters
  • Various end-users who want to know more about the balloon catheters market and the latest technological developments in the balloon catheters market.

Frequently Asked Questions for the Balloon Catheters Market:

1. What are balloon catheters?

  • A balloon catheter is a type of soft catheter that has a balloon attached at the tip of the catheter. This type of catheter is used in various minimally invasive diagnostic and therapeutic procedures such as opening of blockages, dilating vessels, and stent delivery among others.

2. What is the market for balloon catheters?

  • The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032.

3. What are the drivers for the balloon catheter market?

  • The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

4. Who are the key players operating in the balloon catheters market?

  • Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

5. Which region has the highest share in the balloon catheters market?

  • Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

Table of Contents

1. Balloon Catheters Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Balloon Catheters Market Executive Summary

  • 2.1 Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1 The United States
  • 4.2 Europe
  • 4.3 Japan
  • 4.4 China

5. Balloon Catheters Market Key Factors Analysis

  • 5.1. Balloon Catheters Market Drivers
    • 5.1.1 Rising prevalence of cardiovascular diseases
    • 5.1.2 Growing prevalence of brain aneurysms
    • 5.1.3 Increasing prevalence of cancers in the pelvic region
    • 5.1.4 Increase in product development activities by key market players across the globe.
  • 5.2 Balloon Catheters Market Restraints and Challenges
    • 5.2.1 Surgical risk associated with balloon catheters
    • 5.2.2 The increased number of product recalls
  • 5.3 Balloon Catheters Market Opportunities
    • 5.3.1 Ongoing improvement in safety prospects and design-related shortcomings in balloon catheters

6. Balloon Catheters Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Balloon Catheters Market Assessment

  • 7.1 By Product Type
    • 7.1.1 PTA Balloon Catheters
    • 7.1.2 PTCA Balloon Catheters
    • 7.1.3 Occlusion Balloon Catheters
    • 7.1.4 Foley Catheters
    • 7.1.5 Nephrostomy Balloon Catheters
    • 7.1.6 Drug-Eluting Catheters
    • 7.1.7 Others
  • 7.2 By Catheter Type
    • 7.2.1 Fixed Wire
    • 7.2.2 Over-the-Wire
    • 7.2.3 Rapid Exchange
  • 7.3 By Balloon Type
    • 7.3.1 Non-Compliant
    • 7.3.2 Semi-Compliant
    • 7.3.3 Compliant
  • 7.4 By End-User
    • 7.4.1 Hospitals
    • 7.4.2 Specialty Clinics
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.1.2 Canada Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.1.3 Mexico Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.2 Germany Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.3 United Kingdom Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.4 Italy Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.5 Spain Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.6 Rest of Europe Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.2 Japan Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.3 India Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.4 Australia Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.5 South Korea Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.4.2 Africa Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.4.3 South America Balloon Catheters Market Size in USD Million (2022-2032)

8. Balloon Catheters Market Company and Product Profiles

  • 8.1 Medtronic
    • 8.1.1 Company Overview
    • 8.1.2 Company Snapshot
    • 8.1.3 Financial Overview
    • 8.1.4 Product Listing
    • 8.1.5 Entropy
  • 8.2 Boston Scientific Corporation
    • 8.2.1 Company Overview
    • 8.2.2 Company Snapshot
    • 8.2.3 Financial Overview
    • 8.2.4 Product Listing
    • 8.2.5 Entropy
  • 8.3 Abbott
    • 8.3.1 Company Overview
    • 8.3.2 Company Snapshot
    • 8.3.3 Financial Overview
    • 8.3.4 Product Listing
    • 8.3.5 Entropy
  • 8.4 Cook
    • 8.4.1 Company Overview
    • 8.4.2 Company Snapshot
    • 8.4.3 Financial Overview
    • 8.4.4 Product Listing
    • 8.4.5 Entropy
  • 8.5 B. Braun Melsungen AG
    • 8.5.1 Company Overview
    • 8.5.2 Company Snapshot
    • 8.5.3 Financial Overview
    • 8.5.4 Product Listing
    • 8.5.5 Entropy
  • 8.6 Cardinal Health
    • 8.6.1 Company Overview
    • 8.6.2 Company Snapshot
    • 8.6.3 Financial Overview
    • 8.6.4 Product Listing
    • 8.6.5 Entropy
  • 8.7 Terumo Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Company Snapshot
    • 8.7.3 Financial Overview
    • 8.7.4 Product Listing
    • 8.7.5 Entropy
  • 8.8 Stryker
    • 8.8.1 Company Overview
    • 8.8.2 Company Snapshot
    • 8.8.3 Financial Overview
    • 8.8.4 Product Listing
    • 8.8.5 Entropy
  • 8.9 Teleflex Incorporated
    • 8.9.1 Company Overview
    • 8.9.2 Company Snapshot
    • 8.9.3 Financial Overview
    • 8.9.4 Product Listing
    • 8.9.5 Entropy
  • 8.10. Microport Scientific Corporation
    • 8.10.1 Company Overview
    • 8.10.2 Company Snapshot
    • 8.10.3 Financial Overview
    • 8.10.4 Product Listing
    • 8.10.5 Entropy
  • 8.11. BIOTRONIK
    • 8.11.1 Company Overview
    • 8.11.2 Company Snapshot
    • 8.11.3 Financial Overview
    • 8.11.4 Product Listing
    • 8.11.5 Entropy
  • 8.12. Nipro Medical Corporation
    • 8.12.1 Company Overview
    • 8.12.2 Company Snapshot
    • 8.12.3 Financial Overview
    • 8.12.4 Product Listing
    • 8.12.5 Entropy
  • 8.13. BD
    • 8.13.1 Company Overview
    • 8.13.2 Company Snapshot
    • 8.13.3 Financial Overview
    • 8.13.4 Product Listing
    • 8.13.5 Entropy
  • 8.14. Coloplast
    • 8.14.1 Company Overview
    • 8.14.2 Company Snapshot
    • 8.14.3 Financial Overview
    • 8.14.4 Product Listing
    • 8.14.5 Entropy
  • 8.15. Summit Medical (Innovia Medical)
    • 8.15.1 Company Overview
    • 8.15.2 Company Snapshot
    • 8.15.3 Financial Overview
    • 8.15.4 Product Listing
    • 8.15.5 Entropy
  • 8.16. Well Lead Medical Co., Ltd.
    • 8.16.1 Company Overview
    • 8.16.2 Company Snapshot
    • 8.16.3 Financial Overview
    • 8.16.4 Product Listing
    • 8.16.5 Entropy
  • 8.17. Smiths Medical
    • 8.17.1 Company Overview
    • 8.17.2 Company Snapshot
    • 8.17.3 Financial Overview
    • 8.17.4 Product Listing
    • 8.17.5 Entropy
  • 8.18. BACTIGUARD AB
    • 8.18.1 Company Overview
    • 8.18.2 Company Snapshot
    • 8.18.3 Financial Overview
    • 8.18.4 Product Listing
    • 8.18.5 Entropy
  • 8.19. JOTEC GmbH
    • 8.19.1 Company Overview
    • 8.19.2 Company Snapshot
    • 8.19.3 Financial Overview
    • 8.19.4 Product Listing
    • 8.19.5 Entropy
  • 8.20. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 8.20.1 Company Overview
    • 8.20.2 Company Snapshot
    • 8.20.3 Financial Overview
    • 8.20.4 Product Listing
    • 8.20.5 Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Balloon Catheters Market in Global (2022-2032)
  • Table 3: Balloon Catheters Market in Global by Product Type (2022-2032)
  • Table 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
  • Table 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
  • Table 6: Balloon Catheters Market in Global by End-User (2022-2032)
  • Table 7: Balloon Catheters Market in Global by Geography (2022-2032)
  • Table 8: Balloon Catheters Market in North America (2022-2032)
  • Table 9: Balloon Catheters Market in the United States (2022-2032)
  • Table 10: Balloon Catheters Market in Canada (2022-2032)
  • Table 11: Balloon Catheters Market in Mexico (2022-2032)
  • Table 12: Balloon Catheters Market in Europe (2022-2032)
  • Table 13: Balloon Catheters Market in France (2022-2032)
  • Table 14: Balloon Catheters Market in Germany (2022-2032)
  • Table 15: Balloon Catheters Market in United Kingdom (2022-2032)
  • Table 16: Balloon Catheters Market in Italy (2022-2032)
  • Table 17: Balloon Catheters Market in Spain (2022-2032)
  • Table 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
  • Table 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
  • Table 20: Balloon Catheters Market in China (2022-2032)
  • Table 21: Balloon Catheters Market in Japan (2022-2032)
  • Table 22: Balloon Catheters Market in India (2022-2032)
  • Table 23: Balloon Catheters Market in Australia (2022-2032)
  • Table 24: Balloon Catheters Market in South Korea (2022-2032)
  • Table 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Balloon Catheters Market in the Rest of the World (2022-2032)
  • Table 27: Balloon Catheters Market in the Middle East (2022-2032)
  • Table 28: Balloon Catheters Market in Africa (2022-2032)
  • Table 29: Balloon Catheters Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Balloon Catheters Market in Global (2022-2032)
  • Figure 3: Balloon Catheters Market in Global by Product Type (2022-2032)
  • Figure 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
  • Figure 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
  • Figure 6: Balloon Catheters Market in Global by End-User (2022-2032)
  • Figure 7: Balloon Catheters Market in Global by Geography (2022-2032)
  • Figure 8: Balloon Catheters Market in North America (2022-2032)
  • Figure 9: Balloon Catheters Market in the United States (2022-2032)
  • Figure 10: Balloon Catheters Market in Canada (2022-2032)
  • Figure 11: Balloon Catheters Market in Mexico (2022-2032)
  • Figure 12: Balloon Catheters Market in Europe (2022-2032)
  • Figure 13: Balloon Catheters Market in France (2022-2032)
  • Figure 14: Balloon Catheters Market in Germany (2022-2032)
  • Figure 15: Balloon Catheters Market in United Kingdom (2022-2032)
  • Figure 16: Balloon Catheters Market in Italy (2022-2032)
  • Figure 17: Balloon Catheters Market in Spain (2022-2032)
  • Figure 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
  • Figure 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
  • Figure 20: Balloon Catheters Market in China (2022-2032)
  • Figure 21: Balloon Catheters Market in Japan (2022-2032)
  • Figure 22: Balloon Catheters Market in India (2022-2032)
  • Figure 23: Balloon Catheters Market in Australia (2022-2032)
  • Figure 24: Balloon Catheters Market in South Korea (2022-2032)
  • Figure 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Balloon Catheters Market in the Rest of the World (2022-2032)
  • Figure 27: Balloon Catheters Market in the Middle East (2022-2032)
  • Figure 28: Balloon Catheters Market in Africa (2022-2032)
  • Figure 29: Balloon Catheters Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis